Home
>>
Products
>>
Antibodies
>>
Recombinant Antibodies
>
Anti-Human VWF A1 domain Recombinant Antibody

Anti-Human VWF A1 domain Recombinant Antibody

Product Number

YR1265

Alias

科研级 Caplacizumab ( 卡拉西单抗 ), Anti-VWF A1 domain Recombinant Antibody, Research Grade Caplacizumab

Specifications
  • 1mg
  • 5mg
Product Description
Alias科研级 Caplacizumab ( 卡拉西单抗 ), Anti-VWF A1 domain Recombinant Antibody, Research Grade Caplacizumab
Catalog NumberYR1265
Molecular NameCaplacizumab
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeVH-VH
FormulationPBS, pH7.5
BackgroundCaplacizumab (INN, trade name Cablivi) is a bivalent single-domain antibody (VHH) designed for the treatment of thrombotic thrombocytopenic purpura and thrombosis.
CAS Number915810-67-2
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
Molecular Weight27.88 kDa
TargetVWF A1 domain[Homo sapiens]

Login

Don’t have an account?Sign Up Now

Register

Already have an account?Log In Now

Inquire Now